IL50597A - Pharmaceutical preparations containing p)] - 2] - 2 - chloro-a - methyl - a - phenylbenzyl (- oxy [ethyl [- 1 - methylpyrrolidine - Google Patents
Pharmaceutical preparations containing p)] - 2] - 2 - chloro-a - methyl - a - phenylbenzyl (- oxy [ethyl [- 1 - methylpyrrolidineInfo
- Publication number
- IL50597A IL50597A IL50597A IL5059773A IL50597A IL 50597 A IL50597 A IL 50597A IL 50597 A IL50597 A IL 50597A IL 5059773 A IL5059773 A IL 5059773A IL 50597 A IL50597 A IL 50597A
- Authority
- IL
- Israel
- Prior art keywords
- active agent
- composition according
- composition
- administration
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1877072 | 1972-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL50597A true IL50597A (en) | 1977-03-31 |
Family
ID=4435189
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL50597A IL50597A (en) | 1972-12-22 | 1973-12-21 | Pharmaceutical preparations containing p)] - 2] - 2 - chloro-a - methyl - a - phenylbenzyl (- oxy [ethyl [- 1 - methylpyrrolidine |
| IL43883A IL43883A (en) | 1972-12-22 | 1973-12-21 | Pharmaceutical preparations containing P)] - 2] -2-chloro-A-methyl-A-phenylbenzyl (- oxy [ethyl [-1-methylpyrrolidine together with sympathomimetic) |
| IL50597A IL50597A0 (en) | 1972-12-22 | 1976-10-01 | Pharmaceutical compositions comprising 1-methyl-2-(2-(a-methyl-p-chlorodiphenylmethoxy)-ethyl) pyrrolidine |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL43883A IL43883A (en) | 1972-12-22 | 1973-12-21 | Pharmaceutical preparations containing P)] - 2] -2-chloro-A-methyl-A-phenylbenzyl (- oxy [ethyl [-1-methylpyrrolidine together with sympathomimetic) |
| IL50597A IL50597A0 (en) | 1972-12-22 | 1976-10-01 | Pharmaceutical compositions comprising 1-methyl-2-(2-(a-methyl-p-chlorodiphenylmethoxy)-ethyl) pyrrolidine |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3933999A (xx) |
| AT (1) | AT344879B (xx) |
| BE (1) | BE808917A (xx) |
| CS (1) | CS214857B2 (xx) |
| DE (1) | DE2362783C2 (xx) |
| ES (1) | ES421642A1 (xx) |
| FR (1) | FR2211248B1 (xx) |
| GB (2) | GB1454390A (xx) |
| HK (1) | HK53580A (xx) |
| HU (1) | HU166632B (xx) |
| IE (1) | IE40494B1 (xx) |
| IL (3) | IL50597A (xx) |
| NL (1) | NL7317300A (xx) |
| PH (1) | PH11667A (xx) |
| SE (1) | SE413459B (xx) |
| ZA (1) | ZA739653B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5648358A (en) * | 1996-03-05 | 1997-07-15 | Mitra; Sekhar | Compositions and methods for treating respiratory disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3097212A (en) * | 1963-07-09 | N-methyl-z- |
-
1973
- 1973-12-14 SE SE7316967A patent/SE413459B/xx unknown
- 1973-12-17 US US05/425,121 patent/US3933999A/en not_active Expired - Lifetime
- 1973-12-18 GB GB2139076A patent/GB1454390A/en not_active Expired
- 1973-12-18 GB GB5844273A patent/GB1454389A/en not_active Expired
- 1973-12-18 DE DE2362783A patent/DE2362783C2/de not_active Expired
- 1973-12-18 NL NL7317300A patent/NL7317300A/xx not_active Application Discontinuation
- 1973-12-20 PH PH15339A patent/PH11667A/en unknown
- 1973-12-20 ES ES421642A patent/ES421642A1/es not_active Expired
- 1973-12-20 HU HUSA2576A patent/HU166632B/hu unknown
- 1973-12-20 IE IE2309/73A patent/IE40494B1/xx unknown
- 1973-12-20 BE BE139115A patent/BE808917A/xx not_active IP Right Cessation
- 1973-12-20 FR FR7345731A patent/FR2211248B1/fr not_active Expired
- 1973-12-21 IL IL50597A patent/IL50597A/en unknown
- 1973-12-21 CS CS738911A patent/CS214857B2/cs unknown
- 1973-12-21 AT AT1072273A patent/AT344879B/de active
- 1973-12-21 IL IL43883A patent/IL43883A/en unknown
- 1973-12-21 ZA ZA00739653A patent/ZA739653B/xx unknown
-
1976
- 1976-10-01 IL IL50597A patent/IL50597A0/xx unknown
-
1980
- 1980-09-25 HK HK535/80A patent/HK53580A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2211248A1 (xx) | 1974-07-19 |
| SE413459B (sv) | 1980-06-02 |
| IL43883A (en) | 1977-03-31 |
| BE808917A (fr) | 1974-06-20 |
| IE40494B1 (en) | 1979-06-20 |
| FR2211248B1 (xx) | 1977-09-02 |
| HK53580A (en) | 1980-10-03 |
| GB1454390A (en) | 1976-11-03 |
| ES421642A1 (es) | 1976-09-01 |
| DE2362783C2 (de) | 1984-11-29 |
| PH11667A (en) | 1978-05-19 |
| IL43883A0 (en) | 1974-03-14 |
| US3933999A (en) | 1976-01-20 |
| DE2362783A1 (de) | 1974-06-27 |
| ATA1072273A (de) | 1977-12-15 |
| GB1454389A (en) | 1976-11-03 |
| IE40494L (en) | 1974-06-22 |
| NL7317300A (xx) | 1974-06-25 |
| IL50597A0 (en) | 1976-12-31 |
| CS214857B2 (en) | 1982-06-25 |
| ZA739653B (en) | 1975-07-30 |
| AT344879B (de) | 1978-08-10 |
| AU6387473A (en) | 1975-06-26 |
| HU166632B (xx) | 1975-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4753789A (en) | Method for treating nausea and vomiting | |
| EP0651642A1 (en) | Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity | |
| MXPA00012957A (es) | Composicion para dosis oral de liberacion extendida. | |
| AU5972200A (en) | Multilayered tablet for administration of a fixed combination of tramadol and diclofenac | |
| JPS6233204B2 (xx) | ||
| US4929605A (en) | Pharmaceutical composition for piperidinoalkanol derivatives | |
| HRP20040352A2 (en) | Use of flibanserin in the treatment of sexual disorders | |
| GB2053682A (en) | Sustained release pharmaceutical compositions | |
| JPH11349482A (ja) | 医 薬 | |
| AU2018250795B2 (en) | Treatment of adipocytes | |
| US5578628A (en) | Medicaments for the treatment of nausea and vomiting | |
| BRPI0615046A2 (pt) | uso de um composto, e, formulação para administração oral | |
| SK15472001A3 (sk) | Použitie saredutantu a jeho farmaceuticky prijateľných solí na prípravu liečiva použiteľného na liečenie alebo prevenciu porúch nálady, porúch adaptácie alebo stavov úzkosti a depresie | |
| US4032637A (en) | Method of promoting sleep | |
| JPH04346929A (ja) | 光に安定なメシル酸ブロモクリプチン製剤 | |
| AU633496B2 (en) | Composition and method for treatment of gastrointestinal disorders | |
| US5482716A (en) | Medicaments | |
| IL50597A (en) | Pharmaceutical preparations containing p)] - 2] - 2 - chloro-a - methyl - a - phenylbenzyl (- oxy [ethyl [- 1 - methylpyrrolidine | |
| TW383222B (en) | Pharmaceutical composition of bicycloheptane derivatives | |
| GB1572779A (en) | Pharmaceutical compositions | |
| US5232686A (en) | Gastroprotective pharmaceutical preparations containing n-benzyl-n-((1s,5s)-6,6-dimethylbicyclo(3,1,1)-hept-2-ylethoxy-ethyl)-morpholinium salts | |
| US4363809A (en) | Organic compounds | |
| US4388320A (en) | 3-Aminopropoxyaryl derivative in the treatment of tremor | |
| US4225605A (en) | Ergolene or ergoline compounds for treating congestive heart failure | |
| US3851062A (en) | Method of suppressing weight gain |